Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab)

Influence and Variation of the Body Mass Index in Patients Treated with Etanercept for Plaque-Type Psoriasis

(2017) M. Esposito et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Effect of inhibition of interleukin-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages

(2015) I. Voloshyna et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

The Relationship of Obesity With the Severity of Psoriasis

(2015) Patrick Fleming et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Relationship Between Serum IL-12 and p40 Subunit Concentrations and Lipid Parameters in Overweight and Obese Women

(2015) Agnieszka Nikołajuk et al.   Metabolic Syndrome and Related Disorders

Effect of psoriasis activity on serum adiponectin and leptin levels

(2015) Anna Baran et al.   Postepy Dermatologii i Alergologii

Atherosclerosis in psoriatic disease: latest evidence and clinical implications

(2015) Lihi Eder et al.   Therapeutic Advances in Musculoskeletal Disease

Accumulating Evidence for the Association and Shared Pathogenic Mechanisms Between Psoriasis and Cardiovascular-related Comorbidities

(2014) Julia Shlyankevich et al.   AMERICAN JOURNAL OF MEDICINE

Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort

(2014) O. Ahlehoff et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Influence of ustekinumab on body weight of patients with psoriasis: an initial report

(2014) Agnieszka Owczarczyk-Saczonek et al.   Postepy Dermatologii i Alergologii

Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies

(2013) April W. Armstrong et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The association between psoriasis and dyslipidaemia: a systematic review

(2012) C. Ma et al.   BRITISH JOURNAL OF DERMATOLOGY

Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials

(2012) T. Tzellos et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes

(2011) Manish Mishra et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity

(2011) Wolf-Henning Boehncke et al.   EXPERIMENTAL DERMATOLOGY

Psoriasis and metabolic syndrome

(2011) Hidetoshi TAKAHASHI et al.   JOURNAL OF DERMATOLOGY

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

(2010) K Abuabara et al.   BRITISH JOURNAL OF DERMATOLOGY

Positive treatment effects of ustekinumab in psoriasis: Analysis of lesional and systemic parameters

(2010) Manjula REDDY et al.   JOURNAL OF DERMATOLOGY

IL-17 Regulates Adipogenesis, Glucose Homeostasis, and Obesity

(2010) L. A. Zuniga et al.   JOURNAL OF IMMUNOLOGY

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies

(2010) S Prey et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Effects of tumor necrosis factor-α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis

(2009) Jennifer Channual et al.   Dermatologic Therapy

Psoriasis

(2009) Frank O. Nestle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Psoriasis and metabolic disease: epidemiology and pathophysiology

(2008) Rahat S Azfar et al.   CURRENT OPINION IN RHEUMATOLOGY

Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss

(2007) Sun Hye Jung et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY